Automation-compatible, safe assay delivers same-day results to accelerate vaccine and therapeutic antibody development PHILADELPHIA, Oct. 14, 2025 /PRNewswire/ -- Integral...
Black Book’s 2026 international survey of 210 health executives highlights a regional push to replace legacy interoperability engines with open,...
Enterprise Imaging and Cloud Solutions Drive Growth, Customer Satisfaction, and a Clinician-First Experience Across the U.S., Canada, and Government Health...
The recognition highlights Altior Healthcare's strong financial leadership and commitment to sustainable, patient-centered growth. LOS ANGELES, CA / ACCESS Newswire...
PLEASANTON, CA / ACCESS Newswire / October 13, 2025 / Healthcare Triangle Inc. (NASDAQ:HCTI) published a recent press release that...
AUSTIN, Texas and TOKYO, Oct. 13, 2025 /PRNewswire/ -- The global nanomedicine market size reached US$ 169.51 Billion in 2024...
CONVOKE was the first and only pivotal trial to show a statistically significant reduction in experiential negative symptoms of schizophrenia...
Honoring the dedicated professionals who ensure safe, effective, and compassionate care for our community PALM SPRINGS, CA / ACCESS Newswire...
WASHINGTON, DC / ACCESS Newswire / October 13, 2025 / Healthcare providers are under unprecedented strain from rising claim denials,...
The retrospective analysis of nearly 15,000 general anesthesia cases of adults (18 years and older) at the University of Michigan...
The retrospective analysis of nearly 15,000 general anesthesia cases of adults (18 years and older) at the University of Michigan...
HOUSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on October...
PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD)...
Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a...
HOUSTON, TX, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader...
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to...
If approved, it would be the first needle-free insulin option for pediatric patients in 100+ years of insulin therapysBLA submission...
TAMPA, FLORIDA / ACCESS Newswire / October 13, 2025 / Wellgistics Health, Inc. ("Wellgistics" or the "Company") (NASDAQ:WGRX), a leader...
Presentation will cover two-year clinical efficacy, immunogenicity and safety dataData will be presented at an oral session on October 17,...
EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS...